Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: Thymidine labelling index is an independent indicator of clinical outcome

Breast Cancer Research and Treatment

Volumn 68, Issue 2, 2001, Pages 147-157

  Ozmen, Vahit ^a   Cabioglu, Neslihan ^b   Dolay, Kemal ^c   Bilir, Ayhan ^a   Kecer, Mustafa ^a   Aydiner, Adnan ^b   Muslumanoglu, Mahmut ^a   Igci, Abdullah ^a   Bozfakioglu, Yavuz ^a   Dagoglu, Temel ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Haseki Education and Training Hospital   (Turkey)

Author keywords

Anthracycline based neoadjuant chemotherapy; Locally advanced breast cancer; Thymidine labelling index

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; PROGESTERONE RECEPTOR; THYMIDINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LABELING INDEX; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; AXILLA; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; MICROFILAMENT PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; THYMIDINE;

EID: 0034788454     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011956502082     Document Type: Article

References (34)

1. Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery
2. Locally advanced breast cancer
3. Inflammatory breast cancer: A review
4. Local results of irradiation in the primary management of localized breast cancer
5. Natural history and survival of inoperable breast cancer treated with radiotherapy followed by radical mastectomy
6. Locally advanced breast cancer: A review including the M.D. Anderson experience
7. Locally advanced noninflammatory breast cancer
8. Treatment of locally advanced and inflammatory breast cancer
9. Combined modality treatment of stage III and inflammatory breast cancer: M.D. Anderson Cancer Center Experience
10. 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer
11. Thymidine labeling index in breast cancer prognosis
12. In vitro DNA synthesis in freshly separated human breast cancer cells assessed by tritiated thymidine incorporation assay: Relationship to the long-term outcome of patients
13. Proliferative rate of S-phase measurement may affect cure of breast carcinoma
14. The prognostic value of proliferation indices: A study with in vivo bromodeoxyuuridine and Ki-67
15. Prognostic and predictive value of thymidine labelling index in breast cancer
16. Cell kinetics as a prognostic marker in locally advanced breast cancer
17. Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?
18. Cell kinetics as a prognostic indicator in node-negative breast cancer
19. Reporting results of cancer treatment
20. Locally advanced breast cancer
21. Management of locally advanced carcinoma of the breast: II. Inflammatory carcinoma
22. Primary chemotherapy for early and advanced breast cancer
23. Breast tumour response to primary chemotherapy predicts local and distant control as well as survival
24. The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer
25. Clinical course of breast cancer patients with complete pathological primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy
26. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers
27. The periodic health examination
28. Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: A randomized multicenter study
29. 3H-thymidine labelling index
30. Cell kinetics and hormonal receptor status in inflammatory breast carcinoma: Comparison with locally advanced disease
31. Tritiated thymidine labeling index and response in human breast cancer
32. Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study
33. Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer
34. 3 thymidine labelling in human breast tumors